跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 161 条关于
“Afinitor Disperz”
全部
161
临床试验
136
药物
2
机构
0
资讯
23
23小时前
FDA Approves ANI Pharmaceuticals' Generic Everolimus Oral Suspension
去年
FDA Approves Generic Everolimus for Tuberous Sclerosis Complex Brain Tumors
去年
Amneal Pharmaceuticals Gains FDA Approval for Alzheimer's and Oncology Treatments
昨天
FDA Lifts Clinical Hold on Filana's Simufilam, Clearing Phase 2a Trial in TSC-Related Epilepsy
去年
Afinitor Plus Somatuline Significantly Prolongs Survival in GEP-NETs
去年
Optimizing Kidney Cancer Treatment: Keytruda, Inlyta, and Novel Approaches for Non-Clear Cell RCC
6年前
Novartis Agrees to $678M Settlement Over Doctor Kickback Scheme in US
3年前
U.S. Tuberous Sclerosis Drug Market Projected to Reach $1.25 Billion by 2030, Growing at 23.1% CAGR
去年
Sunshine Biopharma Launches Generic Everolimus in Canada's $2.5B Oncology Market
2年前
Lenvatinib and Pembrolizumab Combination Shows Promise in Non-Clear Cell Renal Cell Carcinoma Subtypes
第 1 页,共 3 页
上一页
下一页